Items where Author or Contributor is "Marks, D"

Up a level
Export as [feed] Atom [feed] RSS
Group by: Year | Item Type | Full Text
Jump to: 2018 | 2017 | 2016 | 2015 | 2011 | 2010 | 2009 | 2006 | 2004 | 2003 | 2002 | 2001
Number of items: 30.

2018

Kestler, Andrew; Giesler, Amanda; Buxton, Jane; Meckling, Gray; Lee, Michelle; Hunte, Garth; Wilkins, Jacob; Marks, Dalya; Scheuermeyer, Frank; (2018) Yes, not now, or never: an analysis of reasons for refusing or accepting emergency department-based take-home naloxone. CJEM, 21 (2). pp. 226-234. ISSN 1481-8035 DOI: https://doi.org/10.1017/cem.2018.368
[img]

2017

Foss, A; Locke, L; Lawrence, S; Marks, D; Makowiecka, K; Brammar, L; Woods, C; (2017) Raising awareness and recognition of creativity and innovation. [Conference or Workshop Item] https://researchonline.lshtm.ac.uk/id/eprint/3750294 Full text not available from this repository.

2016

Kestler, Andrew; Buxton, Jane; Meckling, Gray; Giesler, Amanda; Lee, Michelle; Fuller, Kirsten; Quian, Hong; Marks, Dalya; Scheuermeyer, Frank; (2016) Factors Associated With Participation in an Emergency Department-Based Take-Home Naloxone Program for At-Risk Opioid Users. Annals of emergency medicine, 69 (3). pp. 340-346. ISSN 0196-0644 DOI: https://doi.org/10.1016/j.annemergmed.2016.07.027 Full text not available from this repository.

2015

2011

Nherera, L; Marks, D; Minhas, R; Thorogood, M; Humphries, SE; (2011) Probabilistic cost-effectiveness analysis of cascade screening for familial hypercholesterolaemia using alternative diagnostic and identification strategies. Heart (British Cardiac Society), 97 (14). pp. 1175-1181. ISSN 1355-6037 DOI: https://doi.org/10.1136/hrt.2010.213975 Full text not available from this repository.

2010

Marks, D; (2010) Evaluating the ethics of health promotion: acquiring informed consent. In: Thorogood, M; Coomes, Y, (eds.) Evaluating Health Promotion: practice and methods. 3rd ed. OUP, Oxford, UK. ISBN 978-0199569298 https://researchonline.lshtm.ac.uk/id/eprint/3088
[img]

2009

Briggs, Daniel; Rhodes, Tim; Marks, Dalya; Kimber, Jo; Holloway, Greg; Jones, Steve; (2009) Injecting drug use and unstable housing: Scope for structural interventions in harm reduction. Drugs (Abingdon, England), 16 (5). pp. 436-450. ISSN 0968-7637 DOI: https://doi.org/10.1080/09687630802697685 Full text not available from this repository.

Hadfield, SG; Horara, S; Starr, BJ; Yazdgerdi, S; Marks, D; Bhatnagar, D; Cramb, R; Egan, S; Everdell, R; Ferns, G; +11 more... Jones, A; Marenah, CB; Marples, J; Prinsloo, P; Sneyd, A; Stewart, MF; Sandle, L; Wang, T; Watson, MS; Humphries, SE; Steering Group for the Department of Health Familial Hypercholes; (2009) Family tracing to identify patients with familial hypercholesterolaemia: the second audit of the Department of Health Familial Hypercholesterolaemia Cascade Testing Project. Annals of clinical biochemistry, 46 (Pt 1). pp. 24-32. ISSN 0004-5632 DOI: https://doi.org/10.1258/acb.2008.008094 Full text not available from this repository.

2006

Marks, D; Thorogood, M; Humphries, SE; Neil, HAW; (2006) Cascade screening for familial hypercholesterolaemia : implications of a pilot study for national screening programmes. Journal of medical screening, 13. pp. 156-9. ISSN 0969-1413 DOI: https://doi.org/10.1258/096914106778440617 Full text not available from this repository.

Marks, D; Thorogood, M; Neil, SM; Humphries, SE; Neil, HAW; (2006) Cascade screening for familial hypercholesterolaemia: implications of a pilot study for national screening programmes. Journal of medical screening, 13 (3). pp. 156-159. ISSN 0969-1413 DOI: https://doi.org/10.1258/096914106778440617 Full text not available from this repository.

2004

Marks, D; (2004) Evaluating the ethics of health promotion: acquiring informed consent. In: Thorogood, M; Coombes, Y, (eds.) Evaluating Health Promotion: practice and methods. Oxford University Press. https://researchonline.lshtm.ac.uk/id/eprint/11181 Full text not available from this repository.

Marks, D; Thorogood, M; Farrer, JM; Humphries, SE; (2004) Census of clinics providing specialist lipid services in the United Kingdom. Journal of public health (Oxford, England), 26 (4). pp. 353-354. ISSN 1741-3842 DOI: https://doi.org/10.1093/pubmed/fdh176 Full text not available from this repository.

Wonderling, David; Umans-Eckenhausen, Marina AW; Marks, Dalya; Defesche, Joep C; Kastelein, John JP; Thorogood, Margaret; (2004) Cost-effectiveness analysis of the genetic screening program for familial hypercholesterolemia in The Netherlands. Seminars in vascular medicine, 4 (1). pp. 97-104. ISSN 1528-9648 DOI: https://doi.org/10.1055/s-2004-822992 Full text not available from this repository.

2003

Marks, D; Boulton, M; Thorogood, M; (2003) People's understanding of information about inherited risk: experiences of screening for familial hypercholesterolaemia [abstract]. JEpidemiolCommunity Health, 57 (Suppl). A11-. https://researchonline.lshtm.ac.uk/id/eprint/19387 Full text not available from this repository.

Marks, D; Boulton, MG; Thorogood, M; (2003) The Experience of Relatives of Individuals with Familial Hypercholesterolaemia: Social and Psychological Impact of Screening. Technical Report. Report prepared for the British Heart Foundation, London. https://researchonline.lshtm.ac.uk/id/eprint/11176 Full text not available from this repository.

Marks, D; Thorogood, M; Farrer, JM; Humphries, SE; (2003) Census of clinics providing specialist lipid services in The British Isles. Atherosclerosis, 169 (2). p. 362. ISSN 0021-9150 https://researchonline.lshtm.ac.uk/id/eprint/15902 Full text not available from this repository.

Marks, Dalya; Thorogood, Margaret; Neil, H Andrew W; Humphries, Steve E; (2003) A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia. Atherosclerosis, 168 (1). pp. 1-14. ISSN 0021-9150 DOI: https://doi.org/10.1016/s0021-9150(02)00330-1 Full text not available from this repository.

Marks, Dalya; Thorogood, Margaret; Neil, H Andrew W; Wonderling, David; Humphries, Steve E; (2003) Comparing costs and benefits over a 10 year period of strategies for familial hypercholesterolaemia screening. Journal of public health medicine, 25 (1). pp. 47-52. ISSN 0957-4832 DOI: https://doi.org/10.1093/pubmed/fdg010 Full text not available from this repository.

2002

Marks, Dalya; Wonderling, David; Thorogood, Margaret; Lambert, Helen; Humphries, Steve E; Neil, H Andrew W; (2002) Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia. BMJ (Clinical research ed), 324 (7349). 1303-. ISSN 0959-8138 DOI: https://doi.org/10.1136/bmj.324.7349.1303
[img]

Wonderling, D; Umans-Eckenhausen, MAW; Marks, D; Defesche, JC; Kastelein, JJP; Thorogood, M; (2002) A cost-effectiveness analysis of the genetic screening program for familial hypercholesterolemia in the Netherlands. [Conference or Workshop Item] https://researchonline.lshtm.ac.uk/id/eprint/16114 Full text not available from this repository.

2001

Marks, D; Lambert, H; Thorogood, M; Neil, HAW; Humphries, SE; Wonderling, D; (2001) Does screening for a modifiable genetic condition cause stress?: abundance of opinion and paucity of data [Abstract 78]. Journal of epidemiology and community health, 55 (Supple). A20-A21. ISSN 0143-005X https://researchonline.lshtm.ac.uk/id/eprint/19546 Full text not available from this repository.

Marks, D; Thorogood, M; (2001) Screening options for Familial Hypercholesterolaemia: Comparing costs and benefits of two strategies over a ten year period. Technical Report. London School of Hygiene & Tropical Medicine, London. https://researchonline.lshtm.ac.uk/id/eprint/11178 Full text not available from this repository.

This list was generated on Fri Aug 7 06:42:02 2020 BST.